Skip to main content
MGRX
NASDAQ Industrial Applications And Services

Mangoceuticals Secures $493K via Registered Direct Offering at $0.75 per Unit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.425
Mkt Cap
$9.168M
52W Low
$0.162
52W High
$2.75
52W Position info
162% above low
Off High info
85% below high
Rel. Volume
Market data snapshot near publication time

MGRX has more than doubled off its 52-week low of $0.162.

Summary

Mangoceuticals raised approximately $475,000 net through a registered direct offering of 657,000 shares and warrants at $0.75 per unit, providing critical working capital for a company with only $229K in cash and a going concern warning.


Key Events · Financing and Capital Events · MGRX

  • Registered Direct Offering Priced

    657,000 shares plus 657,000 warrants sold at $0.75 per unit, raising $492,750 gross and approximately $475,000 net.

  • Warrant Terms

    Each warrant has a $1.00 exercise price, is exercisable immediately, expires in 5 years, and includes a cashless exercise option at 1.2 shares per warrant.

  • Use of Proceeds

    All net proceeds are earmarked for working capital and general corporate purposes, with no specific allocations.

  • Dilution Impact

    Outstanding shares increase from 21,567,422 to 22,224,422 immediately, with up to 788,400 additional shares issuable upon full warrant exercise.


Analysis · MGRX · Industrial Applications And Services

The company is selling 657,000 shares plus 657,000 warrants at $0.75 per unit, raising roughly $475,000 net. With only $229K in cash as of its last 10-Q and a going concern warning, this capital is critical for near-term survival. The warrants carry a $1.00 exercise price — more than double the current $0.4251 share price — meaning they are unlikely to be exercised soon, but the cashless exercise feature (1.2 shares per warrant) could still add up to 788,400 shares of future dilution. The offering price of $0.75 is above the October 7 closing price of $0.44, suggesting investors accepted a premium for the unit structure, but the deal is small and dilutive to existing holders.

How filings like this one have moved

In the 30 days to Oct 9, 2026, 28.2% of the 1635 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MGRX was trading at $0.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.2M. The 52-week trading range was $0.16 to $2.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Oct 06, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4107
Real-time Price: $0.4251 info
Change: +$0.0144 (+4%) info
Market Cap: $9.168M info
MGRX
Oct 01, 2026, 3:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4921
Real-time Price: $0.4251 info
Change: -$0.067 (-14%) info
Market Cap: $9.168M info
MGRX
Aug 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4021
Real-time Price: $0.4251 info
Change: +$0.023 (+6%) info
Market Cap: $9.168M info
MGRX
Aug 13, 2026, 5:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.625
Real-time Price: $0.4251 info
Change: -$0.1999 (-32%) info
Market Cap: $9.168M info
MGRX
Aug 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7485
Real-time Price: $0.4251 info
Change: -$0.3234 (-43%) info
Market Cap: $9.168M info